KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer

Keyphrases

• Non-small Cell Lung Cancer (NSCLC) 100%
• Polymorphism 100%
• KRAS mutation 100%
• Let-7 100%
• KRAS-LCS6 100%
• SNP 75%
• Lung Cancer 50%
• Etiology 25%
• Lung Adenocarcinoma 25%
• MicroRNA 25%
• Regulatory Molecules 25%
• Smokers 25%
• Let-7 Family 25%
• Clinical Utility 25%
• Oncogene 25%
• Patient Survival 25%
• Downstream Targets 25%
• 3′-untranslated Region (3′-UTR) 25%
• Binding Region 25%
• Functional Polymorphism 25%
• Newly Reported 25%
• Lung Cancer Survival 25%
• Unexpected Findings 25%
• Clinical Outcomes 25%
• RAS Gene Family 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Lung Cancer 100%
• Cancer Survival 33%
• microRNA 33%
• Lung Adenocarcinoma 33%

Biochemistry, Genetics and Molecular Biology

• KRAS 100%
• Single Nucleotide Polymorphism 33%
• Oncogene 11%
• MicroRNA 11%
• Smoking 11%
• Multigene Family 11%
• Cancer Survival 11%
• 3' Untranslated Region 11%